The abstract is read at the publisher; the summary is JClub's.
Telehealth prescribing of buprenorphine for pregnant and postpartum women with opioid use disorder needs further research to guide clinicians and policymakers.
- Why it matters: Access to effective treatment is a key gap for pregnant and postpartum patients with opioid use disorder, and telehealth may help close it.
- What they did: The Viewpoint argues for additional studies to inform how clinicians and policymakers can increase both access and effective use of telehealth buprenorphine prescribing.
- The result: Findings from future research are expected to provide practical guidance for expanding telehealth buprenorphine use in this specific population.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.